Pharmacovigilance and Regulatory Affairs

Global Signal Management Systems and Standards

Signal management is a cornerstone of pharmacovigilance, enabling early detection and evaluation of potential safety risks. Globally, regulatory agencies require a structured, documented process for signal detection, validation, prioritization, assessment, and communication. As pharmacovigilance becomes more data-driven, standardized systems and tools are essential to support the volume and complexity of safety information. Global harmonization efforts, such as ICH E2E and GVP Module IX, provide a framework for consistent signal management across jurisdictions. Signal detection algorithms using statistical disproportionality, machine learning, and real-world evidence offer improved sensitivity and specificity. Tools like EVDAS (EudraVigilance Data Analysis System) and FAERS (FDA Adverse Event Reporting System) are key in centralized signal evaluation. Cross-border data sharing and collaborative platforms strengthen global pharmacovigilance by enabling real-time exchange of emerging safety information. Maintaining alignment with international standards ensures compliance and facilitates timely decision-making. By adopting advanced methodologies and standardized processes, organizations enhance their ability to identify risks early and protect public health.